A Phase 1/1b Study of IAM1363 in HER2 Cancers
Iambic Therapeutics, Inc
Iambic Therapeutics, Inc
Pfizer
Emory University
University of California, Davis
National Cancer Institute (NCI)
Pfizer
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
Guangzhou JOYO Pharma Co., Ltd
Columbia University
Thomas Jefferson University
Blueprint Medicines Corporation
ABM Therapeutics Corporation
Second Affiliated Hospital of Guangzhou Medical University
Universitätsmedizin Mannheim
University of Florida
Quadriga Biosciences, Inc.
AstraZeneca
Celgene
Stanford University
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Angiochem Inc
Memorial Sloan Kettering Cancer Center
Novartis
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, San Francisco
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Vanderbilt-Ingram Cancer Center
Case Comprehensive Cancer Center
Amsterdam UMC, location VUmc
Copharos